Into the infodemic: Countering COVID's medicine myths
As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.
As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.
Communications / 18 December 2020
Some medicines are inappropriate for children, while others require special consideration or monitoring. The KIDS List is a valuable new resource to guide paediatric prescribing.
In focus / 11 December 2020
Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020
#MedSafetyWeek 2020 was the most successful ever. One of the broadest and most active agendas took shape in Egypt, setting a great example for future events.
Around the world / 14 January 2021
As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.
Communications / 18 December 2020
The new episode of the Drug Safety Matters podcast is here. Find why pharmacovigilance scientists should not discount the value of intuition.
Communications / 18 December 2020
Some medicines are inappropriate for children, while others require special consideration or monitoring. The KIDS List is a valuable new resource to guide paediatric prescribing.
In focus / 11 December 2020
Video / 12 November 2020
Video / 02 November 2020
Video / 08 June 2020
Video / 22 October 2020
Video / 10 October 2019
Video / 17 November 2019
Podcast / 23 April 2020
Video / 28 October 2019
Video / 23 May 2018
Video / 06 May 2019
Video / 26 February 2020
Video / 04 January 2017
Video / 08 January 2020